Novel synthetic compound shows promise against drug-resistant bacteria
Researchers have developed a novel synthetic compound called infuzide that shows promising activity against multidrug-resistant bacterial infections. The compound demonstrated effectiveness against resistant strains of Staphylococcus aureus and Enterococcus species in both laboratory and mouse studies, potentially offering a new therapeutic approach for treating serious hospital-acquired infections.
